beta-adrenergic blocking agent


Also found in: Thesaurus, Medical, Legal, Financial, Encyclopedia.

beta-adrenergic blocking agent

ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.beta-adrenergic blocking agent - any of various drugs used in treating hypertension or arrhythmiabeta-adrenergic blocking agent - any of various drugs used in treating hypertension or arrhythmia; decreases force and rate of heart contractions by blocking beta-adrenergic receptors of the autonomic nervous system
acebutolol, Sectral - an oral beta blocker (trade name Sectral) used in treating hypertension
atenolol, Tenormin - an oral beta blocker (trade name Tenormin) used in treating hypertension and angina; has adverse side effects (depression and exacerbation of congestive heart failure etc.)
blocking agent, blocker - a class of drugs that inhibit (block) some biological process
carvedilol - beta blocker that can reduce the progression of heart failure in individuals whose disease is not advanced
Brevibloc, esmolol - intravenous beta blocker (trade name Brevibloc) that acts for only a short time; used primarily for cardiac arrhythmias
Lopressor, metoprolol - beta blocker (trade name Lopressor) used in treating hypertension and angina and arrhythmia and acute myocardial infarction; has adverse side effects (depression and exacerbation of congestive heart failure etc.)
Corgard, nadolol - a beta-adrenergic blocking agent (trade name Corgard) that is used to treat hypertension and angina
pindolol, Visken - an oral beta blocker (trade name Visken) used in treating hypertension
Inderal, propanolol - the first beta blocker (trade name Inderal) used in treating hypertension and angina pectoris and essential tremor
Blocadren, timolol - a beta blocker (trade name Blocadren) administered after heart attacks
References in periodicals archive ?
BYSTOLIC[R] is a beta-adrenergic blocking agent indicated for the treatment of hypertension, to lower blood pressure.
The study is designed to test the hypothesis that the addition of the beta-adrenergic blocking agent BEXTRA(R) (bucindolol HCl) to standard therapy will reduce mortality in patients with moderate to severe congestive heart failure.
The BEST Study is designed to test the hypothesis that the addition of the beta-adrenergic blocking agent bucindolol to standard therapy will reduce mortality in patients with moderate to severe congestive heart failure.